Stocktoria
MYOMO, INC. MYO
NYSE American · XASE · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2017-06-12
MYOMO, INC. financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.9M | $32.6M | $19.2M | $15.6M | $13.9M | $7.6M | $3.8M | $2.4M | $1.6M | $1.1M |
| Gross profit | $26.9M | $23.2M | $13.2M | $10.3M | $10.3M | $5.0M | $2.4M | $1.7M | $1.1M | $821,113 |
| R&D expense | $6.9M | $4.8M | $2.6M | $2.5M | $2.6M | $1.7M | $1.7M | $1.8M | $1.8M | $1.1M |
| SG&A expense | — | — | $18.8M | $18.4M | $18.0M | $13.8M | $11.5M | $10.4M | $5.8M | $3.0M |
| Operating income | -$14.4M | -$6.2M | -$8.2M | -$10.7M | -$10.3M | -$10.5M | -$10.8M | -$10.5M | -$6.5M | -$3.3M |
| Income tax | $504,532 | $365,617 | $156,002 | $69,937 | $88,928 | — | — | — | $0 | $0 |
| Net income | -$15.6M | -$6.2M | -$8.1M | -$10.7M | -$10.4M | -$11.6M | -$10.7M | -$10.3M | -$12.1M | -$3.6M |
| EPS (diluted) | $-0.37 | $-0.16 | $-0.28 | $-1.52 | $-1.89 | — | — | — | — | — |
| Operating cash flow | -$14.5M | -$3.3M | -$6.2M | -$10.2M | -$9.5M | -$9.0M | -$10.3M | -$9.6M | -$6.2M | -$3.2M |
| Free cash flow | -$16.3M | -$4.7M | -$6.3M | -$10.3M | -$9.9M | -$9.1M | -$10.4M | -$9.7M | -$6.2M | -$3.2M |
| Cash & equivalents | $14.1M | $24.4M | $6.9M | $5.3M | $15.5M | $12.2M | $4.5M | $6.5M | $13.0M | $797,174 |
| Inventory | $3.1M | $3.2M | $1.8M | $1.4M | $808,308 | $707,114 | $439,533 | $256,149 | $201,155 | $82,435 |
| Total assets | $38.6M | $42.2M | $14.6M | $10.2M | $20.1M | $14.7M | $6.6M | $8.3M | $14.0M | $1.7M |
| Total liabilities | $27.2M | $17.5M | $5.6M | $3.8M | $4.7M | $3.1M | $4.8M | $1.9M | $1.5M | $6.5M |
| Shareholders' equity | $11.4M | $24.7M | $9.0M | $6.4M | $15.4M | $11.6M | $6.4M | $6.4M | $12.4M | -$17.5M |
Growth · year-over-year · Revenue CAGR 49.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +25.7% | +69.2% | +23.7% | +12.3% | +82.7% | +97.6% | +57.0% | +56.8% | +41.3% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001369290 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.